Cardiovascular Innovations and Applications (Jan 2024)

Atrial Fibrillation Follow-up Investigation to Recover Memory and Learning Trial (AFFIRMING): Rationale and Design of a Multi-center, Double-blind, Randomized Controlled Trial

  • Zhiyan Wang,
  • Yiqun Zhang,
  • Chao Jiang,
  • Rong Hu,
  • Wenli Dai,
  • Yu Kong,
  • Liling Sun,
  • Litao Wu,
  • Hongxu Geng,
  • Chunqi Ren,
  • Xiangyang Zhang,
  • Jia Wang,
  • Hong Jiang,
  • Jianzeng Dong,
  • Changsheng Ma,
  • Xin Du

DOI
https://doi.org/10.15212/CVIA.2023.0080
Journal volume & issue
Vol. 9, no. 1
p. 998

Abstract

Read online

Background: People with atrial fibrillation (AF) have elevated risk of developing cognitive impairment. At present, there is a dearth of randomized controlled trials investigating cognitive impairment management in patients with AF. The Atrial Fibrillation Follow-up Investigation to Recover Memory and learning (AFFIRMING) study is aimed at evaluating the potential for computerized cognitive training to improve cognitive function in patients with AF. Methods: The study is a multi-center, double-blind, randomized controlled study using a 1:1 parallel design. A total of 200 patients with AF and mild cognitive decline without dementia are planned to be recruited. The intervention group will use the adaptive training software with changes in difficulty, whereas the positive control group will use basic training software with minimal or no variation in difficulty level. At the end of 12 weeks, the participants will be unblinded, and the positive control group will stop training. The intervention group will be rerandomized 1:1 to stop training or continue training. All participants will be followed up until 24 weeks. The primary endpoint is the proportion of the improvement of the global cognitive function at week 12 compared with baseline, using the Basic Cognitive Ability Test (BCAT).